Key Statistics
Market Cap$586.94M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.23
52W High$2.73
52W Low$0.57
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees116
Price Performance
1 Week-4.28%
3 Month+23.45%
1 Year+180.26%
FinancialsAnnual · QuiverQuant
Revenue$6.04M
Assets$64.55M
Liabilities$23.98M
Net Income$63.08M loss
About
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the development of gene therapies to cure diseases of blindness. The company is headquartered in Malvern, Pennsylvania.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze OCGN with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.